Result looks okeish.
Starting with sales, 16% is slight bad, but not disastrous. There seems to be some seasonality effect usually Q3/Q4 have higher sales.
EBIDT has improved YoY, however it is reduced QoQ mainly due to increased material costs.
Both interest and depreciation have dragged net profit and EPS down.
They need to grow sales faster to get the operating leverage.
Disclosure: Invested